4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-072168
Chief Medical Officer sold 2,636 shares at $31.27 ($82,428)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farwell Wildon Chief Medical Officer | 2024-06-11 | Sale 10b5-1 | −1,628 | $31.27 | $50,908 | 146,551 | D |
| Farwell Wildon Chief Medical Officer | 2024-06-11 | Sale 10b5-1 | −1,008 | $31.27 | $31,520 | 145,543 | D |
| Open-market sales · 2,636 sh · avg $31.27 · $82,428 | |||||||
Loading xslF345X05/ownership.xml…